2,550 followers
RT @ProfGRoberts: Lebrikizumab (anti-IL13) treatment in uncontrolled asthma associated with reduced subepithelial fibrosis (ie airway remo…
RT @ProfGRoberts: Lebrikizumab (anti-IL13) treatment in uncontrolled asthma associated with reduced subepithelial fibrosis (ie airway remo…
Lebrikizumab (anti-IL13) treatment in uncontrolled asthma associated with reduced subepithelial fibrosis (ie airway remodelling) and improved lung function. https://t.co/D5NtsL3Kj5 @ClinExpAllergy Free to view! https://t.co/SOUwOWLkn7
RT @wheezemd: A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling…
RT @wheezemd: A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling…